GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OSTO:VIMIAN) » Definitions » Buyback Yield %

Vimian Group AB (OSTO:VIMIAN) Buyback Yield % : -7.98 (As of May. 06, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Vimian Group AB's current buyback yield was -7.98%.


Vimian Group AB Buyback Yield % Historical Data

The historical data trend for Vimian Group AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Buyback Yield % Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial - -1.70 -12.78 -0.03 -7.87

Vimian Group AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -8.98 -6.60 -7.87 -7.24

Competitive Comparison of Vimian Group AB's Buyback Yield %

For the Diagnostics & Research subindustry, Vimian Group AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's Buyback Yield % falls into.


;
;

Vimian Group AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Vimian Group AB's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1641.424) / 20850.8618
=-7.87%

Vimian Group AB's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 1611.002) / 22265.3675
=-7.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


Vimian Group AB Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines